Sort
8,912 grants matching “sars cov 2”
Durable Self-cleaning Fluorinated Graphene Oxide Coated N95 Respirators
$178,764Hui Zhao · University Of Nevada Las Vegas · R21 · FY2022 · OH
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19
$178,610Jonathan B Overdevest · Columbia University Health Sciences · K23 · FY2022 · DC
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19
$178,610Jonathan B Overdevest · Columbia University Health Sciences · K23 · FY2024 · DC
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19
$178,610Jonathan B Overdevest · Columbia University Health Sciences · K23 · FY2023 · DC
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19
$178,610Jonathan B Overdevest · Columbia University Health Sciences · K23 · FY2021 · DC
Neurocognitive & neuropsychiatric impact of chemosensory alterations: Implications of olfactory dysfunction in COVID-19
$178,610Jonathan B Overdevest · Columbia University Health Sciences · K23 · FY2025 · DC
Brain ACE2 in Alzheimer's disease in relation to COVID-19
$177,800Yuichiro Justin Suzuki · Georgetown University · R21 · FY2021 · AG
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART
$177,782Shahin Lockman · Brigham And Women'S Hospital · K24 · FY2024 · AI
A prospective study of male factors, fertility, and pregnancy outcomes
$177,509Lauren A Wise · Boston University Medical Campus · R01 · FY2023 · HD
Administrative Core
$177,500Vincent C Bond · Morehouse School Of Medicine · U54 · FY2021 · MD
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)
$177,500Xuyi Yue · Nemours Children'S Hospital, Delaware · R21 · FY2022 · EB
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)
$177,500Xuyi Yue · Nemours Children'S Hospital, Delaware · R21 · FY2023 · EB
Center for Translational Research in Health Disparities
$177,500Vincent C Bond · Morehouse School Of Medicine · U54 · FY2021 · MD
Development of a Targeted Nitric Oxide-Related Drug to treat SARS-CoV-2
$177,500Stuart A Lipton · Scripps Research Institute, The · DP1 · FY2020 · DA
Serum Antibody Profiling with a Carbohydrate Microarray
$177,499Jeffrey Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2
$177,234Lawrence James Purpura · Columbia University Health Sciences · K23 · FY2025 · AI
Neutralization of Primate Immunodeficiency Viruses
$177,065John P Moore · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AI
Clinical Epidemiology of Pediatric COVID-19 and MIS-C
$177,009Carlos Rafael Oliveira · Yale University · K23 · FY2023 · AI
Clinical Epidemiology of Pediatric COVID-19 and MIS-C
$177,009Carlos Rafael Oliveira · Yale University · K23 · FY2024 · AI
Role of host genetics in COVID-19 susceptibility and severity of infection
$177,000Craig B Thompson · Sloan-Kettering Inst Can Research · P30 · FY2020 · CA
RAPID: Effect of Avidity on Association of Fusion Inhibitory Peptides with the HRN Domain of SARS-CoV-2 Spike Protein
$176,854Christopher A Alabi · Cornell University · · FY2020 · ENG
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Clinical Core
$176,817Margaret Juliana McElrath · Seattle Children'S Hospital · U19 · FY2022 · AI
Novel synthetic TLR4 agonists
$176,807Juhienah Khalaf · Inimmune Corporation · R43 · FY2018 · AI
Determinants of Vaccine Responses in Low-Income Countries (LICs)
$176,738Clarissa Valim · Boston University Medical Campus · K24 · FY2025 · AI
COVID-19 transmission in Alaska: geographic and genomic modeling
$176,644Brian M Barnes · University Of Alaska Fairbanks · P20 · FY2022 · GM